Simultaneous determination of belzutifan and cabozantinib, oral agents for renal cell carcinoma, in human plasma using high-performance liquid chromatography.
Аннотация
Belzutifan and cabozantinib are oral drugs for advanced renal cell carcinoma, which display exposure-dependent toxicities. No validated method exists for simultaneously quantifying these drugs in human plasma. In this study, we developed and validated a high-performance liquid chromatography-ultraviolet method for simultaneously quantifying belzutifan and cabozantinib in human plasma. Plasma samples (50 μL) were processed via simple protein precipitation. Chromatographic separation on a C18 column was performed isocratically with 0.5% KH2PO4 (pH 4.5)/acetonitrile (47/53, v/v) at 1.0 mL/min, with UV detection at 230 nm. Performance characteristics (calibration, precision, accuracy, recovery, stability, selectivity, and interference by concomitant drugs) were systematically evaluated. Linear calibration ranges were 50-4,000 ng/mL for belzutifan and 25-4,000 ng/mL for cabozantinib with excellent linearity (r2 ≥ 0.9998). Intra- and interday coefficients of variation were ≤ 5.41% for belzutifan and ≤ 12.25% for cabozantinib. Both analytes were stable under bench-top, short-term, long-term, and freeze-thaw conditions. No interference from endogenous plasma components or six commonly co-administered medications was observed. The newly developed assay for the simultaneous quantification of belzutifan and cabozantinib in human plasma is rapid, requires minimal sample volumes, and demonstrates robust analytical performance.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.